These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 30876423)

  • 21. Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbations.
    Jones PW; Nadeau G; Small M; Adamek L
    Respir Med; 2014 Jan; 108(1):129-35. PubMed ID: 24041746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics and risk factors for inconsistency between the risk of exacerbations and the severity of airflow limitation in COPD based on GOLD 2017: A retrospective, cross-sectional study.
    Huang WC; Wu MF; Chen HC; Hsu JY;
    PLoS One; 2018; 13(3):e0193880. PubMed ID: 29529075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses.
    Kim S; Oh J; Kim YI; Ban HJ; Kwon YS; Oh IJ; Kim KS; Kim YC; Lim SC
    BMC Pulm Med; 2013 Jun; 13():35. PubMed ID: 23731868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Could Disease Severity and Inflammatory Markers (IL-6, Hs-CRP, TNF-α) be Related to Frailty in COPD? A Prospective Study.
    R S; M N; L D; N K; G S; Kk B
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The evaluation of a remote support program on quality of life and evolution of disease in COPD patients with frequent exacerbations.
    Alcazar B; de Lucas P; Soriano JB; Fernández-Nistal A; Fuster A; González-Moro JM; Arnedillo A; Sidro PG; de Los Monteros MJ
    BMC Pulm Med; 2016 Nov; 16(1):140. PubMed ID: 27821164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COPD in Taiwan: a National Epidemiology Survey.
    Cheng SL; Chan MC; Wang CC; Lin CH; Wang HC; Hsu JY; Hang LW; Chang CJ; Perng DW; Yu CJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2459-67. PubMed ID: 26648708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent and Newly Developed Chronic Bronchitis Are Associated with Worse Outcomes in Chronic Obstructive Pulmonary Disease.
    Kim V; Zhao H; Boriek AM; Anzueto A; Soler X; Bhatt SP; Rennard SI; Wise R; Comellas A; Ramsdell JW; Kinney GL; Han MK; Martinez CH; Yen A; Black-Shinn J; Porszasz J; Criner GJ; Hanania NA; Sharafkhaneh A; Crapo JD; Make BJ; Silverman EK; Curtis JL;
    Ann Am Thorac Soc; 2016 Jul; 13(7):1016-25. PubMed ID: 27158740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort.
    Lee JY; Chon GR; Rhee CK; Kim DK; Yoon HK; Lee JH; Yoo KH; Lee SH; Lee SY; Kim TE; Kim TH; Park YB; Hwang YI; Kim YS; Jung KS
    J Korean Med Sci; 2016 Apr; 31(4):553-60. PubMed ID: 27051239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comorbidity in chronic obstructive pulmonary disease. Related to disease severity?
    Echave-Sustaeta JM; Comeche Casanova L; Cosio BG; Soler-Cataluña JJ; Garcia-Lujan R; Ribera X
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1307-14. PubMed ID: 25429213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
    Kawamatawong T; Onnipa J; Suwatanapongched T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of comorbid heart disease on dyspnea and health status in patients with COPD - a cohort study.
    Giezeman M; Hasselgren M; Lisspers K; Ställberg B; Montgomery S; Janson C; Sundh J
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3857-3865. PubMed ID: 30568437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical frailty characteristics have a differential impact on symptoms as measured by the CAT score: an observational study.
    Medina-Mirapeix F; Bernabeu-Mora R; Giménez-Giménez LM; Escolar-Reina P; Gacto-Sánchez M; de Oliveira-Sousa SL
    Health Qual Life Outcomes; 2018 Jul; 16(1):140. PubMed ID: 30012169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimism is associated with respiratory symptoms and functional status in chronic obstructive pulmonary disease.
    Koo HK; Hoth KF; Make BJ; Regan EA; Crapo JD; Silverman EK; DeMeo DL
    Respir Res; 2022 Jan; 23(1):19. PubMed ID: 35093071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease.
    Miravitlles M; Huerta A; Valle M; García-Sidro P; Forné C; Crespo C; López-Campos JL
    Int J Chron Obstruct Pulmon Dis; 2015; 10():367-77. PubMed ID: 25733826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting.
    Bollmeier SG; Seaton TL; Prosser TR; Chou YT; Reckenberg K; Hahn B; Stanford RH; Ray R
    J Am Pharm Assoc (2003); 2019; 59(4):479-488.e1. PubMed ID: 31126830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frailty and Exacerbation of Chronic Obstructive Pulmonary Disease: Is There Any Association?
    Nishimura K; Kusunose M; Sanda R; Shibayama A; Nakayasu K
    Int J Chron Obstruct Pulmon Dis; 2024; 19():1131-1139. PubMed ID: 38807967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of CAT (COPD Assessment Test) scores in a population of patients with COPD in central and Eastern Europe: The POPE study.
    Miravitlles M; Koblizek V; Esquinas C; Milenkovic B; Barczyk A; Tkacova R; Somfay A; Zykov K; Tudoric N; Kostov K; Zbozinkova Z; Svoboda M; Sorli J; Krams A; Valipour A
    Respir Med; 2019 Apr; 150():141-148. PubMed ID: 30961941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and diagnosis of chronic obstructive pulmonary disease among smokers at risk. A comparative study of case-finding vs. screening strategies.
    Sansores RH; Ramírez-Venegas A; Hernández-Zenteno R; Mayar-Maya ME; Pérez-Bautista OG; Velázquez Uncal M
    Respir Med; 2013 Apr; 107(4):580-6. PubMed ID: 23313037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.
    Raluy-Callado M; Lambrelli D; MacLachlan S; Khalid JM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():925-37. PubMed ID: 25999708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.